Protagonist Stock 120%, Fund Outlook and Exit Signals
A hedge fund's sizable exit from Protagonist Therapeutics highlights how insiders and funds shape biotech stock moves...
A quick guide to reputable sources for index level data, plus tips on choosing datasets and validating their reliability for analysis.
24,978 articlesA hedge fund's sizable exit from Protagonist Therapeutics highlights how insiders and funds shape biotech stock moves...
PureCycle (PCT) is expanding its recycling footprint, and the Q4 2025 earnings call could reshape how investors value...
A new wave of crypto optimism centers on greener tech and Solana’s efficiency. This piece breaks down what back? cryp...
Bitcoin vaulted toward $70,000 at the U.S. market open as oil surged and equities extended losses, pointing to struct...
A fresh stake in SSR Mining hints at growing conviction in gold exposure. This article breaks down what the stake mea...
Market chatter links the billionaire investor against Nvidia to a new stake in Adobe, potentially signaling a strateg...
Global defense markets are shifting as the US, Russia, and China advance missile programs. This report examines inves...
As mortgage markets wobble in March 2026, Ninja Selling’s Larry Kendall champions a habit-first approach for loan off...
Analysts kicked off the week with a wave of fresh calls on major names, signaling a mixed tone across consumer, tech ...
AI excitement can push stocks higher fast, but pullbacks test investors. This guide explains how to read a bull marke...
Berkshire Hathaway just sent a bold signal to the market by resuming share buybacks after a long pause. This article ...
Netflix has transformed how we watch TV, but investors are asking if the stock can reach $200. This article breaks do...